All lobbying filings

AVENUE SOLUTIONS

Lobbying for INCYTE CORPORATION · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $60,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 4

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act

Lobbying activity 2

Health Issues

Issues related to 340b; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)

Medicare/Medicaid

Issues related to Medicaid rebates; H.R. 946/S. 1862, Orphan Cures Act; Health care issues H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); Issues related to Most Favored Nation (MFN) drug pricing proposal

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.